Maintenance Dose Strategy Many researchers and clinicians are exploring reduced maintenance dosing as a middle ground between full-dose treatment and complete discontinuation
Dose reduction or discontinuation may be necessary if you develop: Persistent, intolerable gastrointestinal symptoms despite supportive measures Acute pancreatitis (discontinue permanently) Severe hypoglycemia, particularly if taking concurrent insulin or sulfonylureas Acute kidney injury or worsening renal function Gallbladder disease symptoms (abdominal pain, jaundice) Diabetic retinopathy complications (particularly with semaglutide) Severe hypersensitivity reactions including anaphylaxis or angioedema Pregnancy or plans for pregnancy (for semaglutide, discontinue at least two months before planned conception
Retatrutide includes GLP-1 receptor activity, but it is designed as a triple agonist that also targets GIP and glucagon receptors
Semaglutide has consistently demonstrated better reductions in HbA1c and body weight compared to placebo and a variety of active comparators, including sitagliptin, exenatide extended release, insulin glargine, dulaglutide, canagliflozin, and liraglutide
Bottom Line GLP-1 medications are reshaping obesity treatment, but they are not magic weight-loss solutions or performance enhancers
Then, instead of chasing more and more powerful injections, the diabetes and weight loss market may pivot to perfecting techniques, aiming to reduce side effects or lower muscle loss while upping fat loss, Jonsson said
